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ABSTRACT
Investigates the effects of two well-known carbamate~, physostigmine and pyridostiginine against
organophosphorous compound and nerve gas toxicity. Physostigmine pretreatment for 30 min
enhanced the survival time of rats against DFP intoxication whereas it did not have any effect with
sarin poisoning. However, pyridostigmine pretreatment did not produce any significant effect on
survival time either against DFP or sarin intoxication. Treatment with atropine along with carbamates
further enhanced significantly the survival time against DFP poisoning.
I. INTRODUCTION
The prophylaxis with physostigmine and atropine
varies in effectiveness in different animal speciesl.
Physostigmine has a short duration of action and is
known to cross the blood-brain barrier in rats2 and
dogs3. Whereas, pyridostigmine has a longer duration
of action and cannot cross the blood-brain barrier4.
In the present investigation, the effects of two
well-known carbamates, physostigmine and
pyridostigmine, have been compared as prophylactic
agents against organophosphorous compound (OPC)
and nerve gas toxicity by means of survival time
measurements.
fluoridate (sarin), (subgroups 4-6). The survival times
were measured or observed up to 24 hr in each case.
For the measurement of survival times, the time of
administration of DFP or sarin was considered as zero
time. Fresh aqueous solutions ofDFP (LD5() 3.3 mg/kg,
sc) and sarin (LD5() 203.4 .ug/kg, sc) were prepared each
time before administration. The purity of DFP and sarin
used were established by IR spectroscopic analysis.
A maxi~um sign-fre~ dose5.6 of an aqueous solution
of physostigmine and pyridostigmine (0.1 mg/kg, im)
were administered to each animal 30 min prior to the
challenge dose of DFP or sarin in their respective
subgroups in groups II and III and their survival times
were noted.
To each of the animals of groups IV and V of
Table 1, an additional dose of atropine (10 mg/Yg, ip),
prepared in distilled water, was administered within 30 s
of OPC treatment, with other details remaining exactly
the same as described for groups II and III.
2. MA TERIALS AND METHODS
Male albino rats of Wistar strain (body weight
125+ 10 g), fed on Gold Mohur laboratory animal feed
at the rate of 17 9 per rat per day, were divided into
five groups consisting of six subgroups each. There were
five animals in each subgroup. Group J was the control
in which animals were administered 2, 4 and 8 LDso
doses of diisopropyl phosphorofluoridate (DFP)
(subgroups 1-3) and methyl isopropyl phosphono-
3. RESULTS AND DISCUSSION
Gordon, et aJ6, on the basis of studies of protection
of animals against poisoning with OPCs by carbamate
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Effect or treatment with phy-tigmine, pyridostigmine and atropine on survival time or rats intoxicated
with DFP and sarin
Table 1
DFP(mg/kg)
Group Trcatment
26.4
(8LDSO>
14.2:!:0.38
25.8:!:0.68
8.0:!:0.45
>24hr
6.6
(2LD~
13.2
(4LDso)
25.0:t2.60
>24hr
9.0:t0'.45
47.6::t3.70
>24hr
l'.4::tO.50
>24hr
I. Nil
II .Physostigmine
111. Fyridostigmine
IV. Physo~tigmine +
atropine
V. pyridostigmine +
atropine
Values are mean :t SE
>24hr
4.2:tO.12 4.5:tO.22 4.2:tO.12>24hr >24hr >24hr
In groups IV and V, when atropine, an additional
cholionolytic and antimuscarinic agent, was used as an
after-treatment drug against OPC poisoning along with
respective carbamate pretreatment, the survival time
figures increased greatly in case of DFP (P < 0.001 as
compared to corresponding subgroups in control
group I) but not in case of sarin challenge. The
protective action of atropine against OPC toxicity has
been widely studied8.
Indeed, studies on rodents and non-human primates
have shown that combination of pyridostigmine
prophylaxis with atropine and pyridine-2-aldoxime
rnethiodide (P-2AM) therapy can protect against several
multiples of a normally lethal dose of Soman6.7.
It is concluded from the present study, that
physostigmine is a better prophylactic agent against
intoxication by OPCs than pyridostigmine and may
prove useful at times of chemical warfare .
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pretrejitment, found that the dose of carbamate is not
critical; the protection being essentially constant for
doses ranging from 0.5 to 4 times the maximum sign-free
dose.
In the present study, group I in Table 1, shows that
in all the doses tested (2, 4 and 8 LD50)' the survival
times are more against DFP challenge than against sarin ,
and followed a reciprocal relationship with
concentration. It is not surprising, as the sarin is 16.2
times more toxic than DFP as calculated from their
LD5o values.
In group II, when an additional drug physostigmine
was administered 30 min prior to the challenge doses
of OPCs, the survival times against DFP challenge, in
all doses, were drastically increased (P < 0.001 as
compared to the corresponding subgroups in control
group I), because of the protective action of
physostigmine on DFP to,xicity. However, the same
increase was not possible against sarin challenge, at
these doses, probably due to quicker dealkylation or
'ageing' of enzyme-inhibitor complex, caused by greater
toxicity of sarin7.
In group Ill, under similar pretreatment with
pyridostigmine followed by intoxication by OPCs, there
was a significant decrease in survival times in all the
doses (P < 0.001 for DFP and p < 0.05 for sarin as
compared to corresponding subgroups in control
group I). This indicates that under similar conditions
pyridostigmine does not have as much protective action
as physostigmine. Also, the doses of sarin/DFP seem
to be too high for effective action of pyridostigmine .
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